Join the limbic and a panel of Australian experts to discuss the highlights from ERS 2020 International Congress and what...
This is the first of three features in the limbic reporting on the ADVENT Advances in Type 2 Inflammatory Diseases...
More than a quarter of Australians who use inhaled corticosteroids (ICS) to control their asthma are dispensed high and potentially...
A combination of durvalumab and standard first-line chemotherapy has shown promise for the management of untreated patients with advanced mesothelioma...
Specialists utilising Victoria’s voluntary assisted dying laws to assist terminally-ill patients say there is a desperate need for more doctors...
An open-label extension trial of dupilumab for up to three years in adults and adolescents with moderate-to-severe asthma has confirmed...
People with thoracic cancers are at higher risk of death from COVID-19 with one in three dying, according to the...
Use of a biomarker-based strategy to safely reduce corticosteroid use in severe asthma did not show a significant impact –...
Translation and implementation of clinical guidelines into practice remains an ongoing challenge, says Professor Ian Yang, as evidenced by responses...
When a child gets admitted to hospital for their asthma it is an opportunity to make a plan for staying...
